ATS 2024 Final Program

Click on the session title to view the speakers

348

WEDNESDAY • MAY 22

624 Cellular and Molecular Characterization of

310 Phosphoproteome of Thromboxane Receptor and Coupling With Gq Protein in Neonatal Persistent Pulmonary Hypertension 311 Pulmonary Artery Flow Using 4D Cardiac Magnetic Resonance Imaging 312 Higher Dead Space and Tidal Volumes at Anaerobic Threshold in WHO Group 1 Pulmonary Hypertension Compared to WHO Group 2 Pulmonary Hypertension Detected by CPET Using Transcutaneous CO2 Monitoring 313 The Use of Non-invasive Cardiopulmonary Exercise Testing to Evaluate Patients Treated for Exercise-induced Pulmonary Hypertension 314 Optimising Thresholds for the Detection of Pulmonary Hypertension (PH) and Pre-capillary PH Using Automatic Measurement of TRJV on Echocardiography 315 Mixed Venous Oxygen Saturation May Be a Better Prognosticator Than Cardiac Index in Scleroderma Associated Pulmonary Arterial Hypertension 316 Pulmonary Gas Exchange in Patients With Heart Failure With Preserved Ejection Fraction: The Effects of Pulmonary Vascular Disease 317 30 Hours at High Altitude (2500m) in Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension - Adverse Events and Effect of Oxygen Therapy 318 Cardiac Effort Is Less Variable Than Six-minute Walk Distance, Correlates With Hemodynamics and Is Consistent With REVEAL 2.0 Risk Score in a Sub-study of the TORREY Phase 2 PAH Trial 319 Hemodynamic and Blood Volume Assessment in a Cohort of Preload Insufficiency Subject at Submaximal Exercise 320 Anatomic and Alveolar Dead Space Components in Pulmonary Arterial Hypertension (PAH) During Exercise by Breath-by-Breath Volumetric Capnography

Peripheral Glia in the Lung and Comparison Across Organs and Species

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D109 NOW WE GOT BAD BLOOD: RSF/PC JOINT SESSION ON PULMONARY VASCULAR DISEASE 11:00 a.m. - 1:00 p.m. San Diego Convention Center Room 28C-E (Upper Level) Poster Viewing 11:00-11:45 Discussion 11:45-1:00 301 Imaging of Blood Clots in Patients With Acute Pulmonary Embolism Using a Novel Tracer Binding to Fresh Fibrin 302 Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in Patients With Pulmonary Embolism and Acute Cor Pulmonale: In Hospital Outcomes and Mortality 303 Evaluating Lung Ultrasound as a Diagnostic Tool for Pulmonary Embolism a Diagnostic Accuracy Meta Analysis 304 Thrombus In Situ Unveiled: Distinguishing Pulmonary Artery Thrombosis From Pulmonary Embolism 305 Unraveling the Lung Vascular Remodeling in Pulmonary Arterial Hypertension Using a Quantitative Digital Pathology Software 306 Same-day and Six-week Repeatability of Hyperpolarized 129 Xe MRI Measures in Patients With Pulmonary Arterial Hypertension 307 Transformer Based Deep Learning Method Reveals Novel Drugs and Comorbidity Associations in Pulmonary Arterial Hypertension 308 Network Propagation Analysis to Elucidate the Molecular Mechanisms Underlying Drug-induced Pulmonary Arterial Hypertension 309 Changes in the Pulmonary Vasculature in Response

to Pulmonary Arterial Hypertension Therapies Using Contrast-free Pulmonary Angiography

ATS 2024 • San Diego, CA